Gapping up
In reaction to strong earnings/guidance: ZAZA +31.4%, FUEL +15.8%, CYBR +14.4%, AMOT +13.1%, MARA +10.3%, ABAC +10.1%, ASTI +9.9%, RSTI +9.6%, OXGN +8.6%, HUBS +5.9%, ENZY +4.9%, ICLD +4.5%, IMOS +4.4%, CNAT +4.3%, AGRO +3.5%, SFS +3.2%, SAND +3.1%, ARCW +2.6%, FLY +2.6%, RWLK +2.5%, WMT +2.2%, PNNT +2%, EVRY +1.6%, VIAB +1.1%, TSEM +1%
M&A news: DWA +23.4% (reports that Hasbro (HAS) in discussions to purchase DWA), INTL +3% (acquires G.X. Clarke & Co), PT +1.7% (cont momentum on takeover spec)
Other news: IMOS +4.4% (Board authorized the repurchase of $15 mln of the company's common stock), ERIC +2.5% (provides updates on growth and development at its Capital Markets day), SRPT +1.4% (announced that it has initiated dosing in a clinical study of eteplirsen for the treatment of Duchenne muscular dystrophy), TWTR +1.4% (followng analyst day), ACT +0.9% (announces FDA acceptance of sNDA for SAPHRIS for the treatment of bipolar I disorder in pediatric patients), GME +0.6% (disclosed that its Board has authorized $500 mln of funds to be used in the company's share repurchase plan)
Analyst comments: TUBE +4.5% (initiated with a Overweight at Piper Jaffray), GNW +2.2% (upgraded to Outperform from Mkt Perform at Raymond James), BRCM +2.1% (upgraded to Buy from Neutral at Goldman), PHG +1.6% (added to Europe Best Ideas list at Morgan Stanley), HCP +1.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley ), DGX +1% (upgraded to Buy from Hold at Deutsche Bank), UTEK +0.9% (initiated with a Buy at Stifel)